IOL CHEMICALS & PHARM. | ALEMBIC | IOL CHEMICALS & PHARM./ ALEMBIC |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 31.9 | 42.8% | View Chart |
P/BV | x | 1.6 | 1.2 | 132.6% | View Chart |
Dividend Yield | % | 1.0 | 2.3 | 43.2% |
IOL CHEMICALS & PHARM. ALEMBIC |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ALEMBIC Mar-23 |
IOL CHEMICALS & PHARM./ ALEMBIC |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 87 | 616.9% | |
Low | Rs | 272 | 56 | 490.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 5.0 | 7,620.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 3.1 | 754.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 3.4 | 927.9% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.20 | 181.8% | |
Avg Dividend yield | % | 1.0 | 3.1 | 32.0% | |
Book value per share (Unadj.) | Rs | 256.8 | 80.9 | 317.3% | |
Shares outstanding (eoy) | m | 58.71 | 256.78 | 22.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 14.4 | 7.4% | |
Avg P/E ratio | x | 17.1 | 22.7 | 75.2% | |
P/CF ratio (eoy) | x | 12.8 | 21.0 | 61.2% | |
Price / Book Value ratio | x | 1.6 | 0.9 | 178.8% | |
Dividend payout | % | 16.9 | 70.1 | 24.1% | |
Avg Mkt Cap | Rs m | 23,743 | 18,298 | 129.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 240 | 699.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,272 | 1,742.4% | |
Other income | Rs m | 256 | 643 | 39.9% | |
Total revenues | Rs m | 22,427 | 1,915 | 1,171.1% | |
Gross profit | Rs m | 2,257 | 297 | 759.2% | |
Depreciation | Rs m | 462 | 67 | 686.6% | |
Interest | Rs m | 165 | 5 | 3,541.9% | |
Profit before tax | Rs m | 1,887 | 868 | 217.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 62 | 801.3% | |
Profit after tax | Rs m | 1,391 | 806 | 172.6% | |
Gross profit margin | % | 10.2 | 23.4 | 43.6% | |
Effective tax rate | % | 26.2 | 7.1 | 368.6% | |
Net profit margin | % | 6.3 | 63.4 | 9.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,721 | 561.6% | |
Current liabilities | Rs m | 5,025 | 838 | 599.6% | |
Net working cap to sales | % | 20.9 | 69.4 | 30.2% | |
Current ratio | x | 1.9 | 2.1 | 93.7% | |
Inventory Days | Days | 43 | 5,038 | 0.9% | |
Debtors Days | Days | 8 | 673 | 1.2% | |
Net fixed assets | Rs m | 11,017 | 20,324 | 54.2% | |
Share capital | Rs m | 587 | 514 | 114.3% | |
"Free" reserves | Rs m | 14,490 | 20,267 | 71.5% | |
Net worth | Rs m | 15,077 | 20,780 | 72.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 22,046 | 93.8% | |
Interest coverage | x | 12.5 | 187.7 | 6.6% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.1 | 1,857.2% | |
Return on assets | % | 7.5 | 3.7 | 204.5% | |
Return on equity | % | 9.2 | 3.9 | 237.9% | |
Return on capital | % | 13.6 | 4.2 | 324.0% | |
Exports to sales | % | 26.7 | 1.2 | 2,170.2% | |
Imports to sales | % | 0 | 2.4 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 16 | 37,819.5% | |
Imports (cif) | Rs m | NA | 30 | 0.0% | |
Fx inflow | Rs m | 5,930 | 16 | 37,819.5% | |
Fx outflow | Rs m | 6,052 | 30 | 20,240.1% | |
Net fx | Rs m | -122 | -14 | 855.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 389 | 314.7% | |
From Investments | Rs m | -1,200 | 73 | -1,644.7% | |
From Financial Activity | Rs m | -41 | -464 | 8.9% | |
Net Cashflow | Rs m | -18 | -2 | 766.7% |
Indian Promoters | % | 48.2 | 70.9 | 68.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 1.1 | 153.2% | |
FIIs | % | 1.4 | 1.1 | 130.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 29.1 | 177.9% | |
Shareholders | 130,003 | 99,130 | 131.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | ALEMBIC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | -0.87% | 0.97% |
1-Month | 5.64% | 17.41% | 2.08% |
1-Year | -1.14% | 57.67% | 55.37% |
3-Year CAGR | -12.91% | -5.48% | 15.04% |
5-Year CAGR | 16.34% | 17.63% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the ALEMBIC share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of ALEMBIC the stake stands at 70.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of ALEMBIC.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
ALEMBIC paid Rs 2.2, and its dividend payout ratio stood at 70.1%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of ALEMBIC.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.